Over the past several decades, the idea of what counts as corporate value has changed dramatically. Firms across technology, healthcare, and life sciences increasingly derive competitive advantage from intangible assets rather than physical capital. These assets include patents, software, proprietary data, and algorithms. As a result, lenders and private credit providers now finance companies whose
